Chemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin

다국어 초록 (Multilingual Abstract)

The burden of increasing morbidity and mortality due to prostate cancer imposes a need for new, effective measures of prevention in daily life. The influence of lifestyle on carcinogenesis in Asian men who migrate to Western cultures supports a causal role for dietary, environmental, and genetic factors in the epidemiology of prostate cancer. Chemoprevention, a prophylactic approach that uses nontoxic natural or synthetic compounds to reverse, inhibit, or prevent cancer by targeting specific steps in the carcinogenic pathway, is gaining traction among health care practitioners. Soy isoflavones and curcumin, staples of the Asian diet, have shown promise as functional factors for the chemoprevention of prostate cancer because of their ability to modulate multiple intracellular signaling pathways, including cellular proliferation, apoptosis, inflammation, and androgen receptor signaling. Recent evidence has revealed the DNA damage response (DDR) to be one of the earliest events in the multistep progression of human epithelial carcinomas to invasive malignancy. Soy isoflavones and curcumin activate the DDR, providing an opportunity and rationale for the clinical application of these nutraceuticals in the chemoprevention of prostate cancer.

참고문헌 (Reference)

1 Choi YH, "p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells" 91 : 164-173, 2000

2 Baur JA, "Therapeutic potential of resveratrol: the in vivo evidence" 5 : 493-506, 2006

3 Dorai T, "Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells" 60 : 1-17, 2004

4 Dorai T, "Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo" 47 : 293-303, 2001

5 Dorai T, "Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein" 4 : 1-6, 2000

6 Dorai T, "Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells" 3 : 84-93, 2000

7 Kumar NB, "The specific role of isoflavones in reducing prostate cancer risk" 59 : 141-147, 2004

8 Hong JH, "The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo" 9 : 147-152, 2006

9 Jackson SP, "The DNA-damage response in human biology and disease" 461 : 1071-1078, 2009

10 Ide H, "Testosterone augments polyphenol-induced DNA damage response in prostate cancer cell line, LNCaP" 102 : 468-471, 2011

11 Kurahashi N, "Soy product and isoflavone consumption in relation to prostate cancer in Japanese men" 16 : 538-545, 2007

12 Perabo FG, "Soy isoflavone genistein in prevention and treatment of prostate cancer" 11 : 6-12, 2008

13 Ozasa K, "Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men" 95 : 65-71, 2004

14 Tyagi A, "Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells" 26 : 1978-1987, 2005

15 Bieberich CJ, "Prostate-specific and androgen-dependent expression of a novel homeobox gene" 271 : 31779-31782, 1996

16 Palapattu GS, "Prostate carcinogenesis and inflammation: emerging insights" 26 : 1170-1181, 2005

17 Whittemore AS, "Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada" 87 : 652-661, 1995

18 Gronberg H, "Prostate cancer epidemiology" 361 : 859-864, 2003

19 Miyanaga N, "Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen" 103 : 125-130, 2012

20 Namiki M, "Prostate Cancer Working Group report" 40 (40): 70-75, 2010

21 Lieberman R, "Progress in prostate cancer chemoprevention: modulators of promotion and progression" 58 : 835-842, 2001

22 Kurahashi N, "Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center" 26 : 5923-5929, 2008

23 Shenouda NS, "Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro" 49 : 200-208, 2004

24 Dhillon N, "Phase II trial of curcumin in patients with advanced pancreatic cancer" 14 : 4491-4499, 2008

25 Cheng AL, "Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions" 21 (21): 2895-2900, 2001

26 Sharma RA, "Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer" 7 : 1894-1900, 2001

27 Bartkova J, "Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints" 444 : 633-637, 2006

28 Li L, "Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis" 101 : 2351-2362, 2004

29 Surh YJ, "NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals" 2 : 313-317, 2008

30 Banerjee S, "Multi-targeted therapy of cancer by genistein" 269 : 226-242, 2008

31 Vazquez-Martin A, "Metformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response" 10 : 1499-1501, 2011

32 Yan L, "Meta-analysis of soy food and risk of prostate cancer in men" 117 : 667-669, 2005

33 Singh RP, "Mechanisms of action of novel agents for prostate cancer chemoprevention" 13 : 751-778, 2006

34 Srivastava RK, "Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1)" 6 : 2953-2961, 2007

35 Tanaka M, "Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers" 12 : 247-252, 2009

36 Akaza H, "Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration" 32 : 296-300, 2002

37 Park JW, "Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells" 286 : 721-725, 2001

38 Li Y, "Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway" 8 : 2369-2377, 2002

39 금영삼, "Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin" OXFORD UNIV PRESS 27 (27): 475-482, 200603

40 Makela S, "Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells" 217 : 310-316, 1998

41 Edwards J, "HER2 and COX2 expression in human prostate cancer" 40 : 50-55, 2004

42 Parkin DM, "Global cancer statistics, 2002" 55 : 74-108, 2005

43 Birnbaum MJ, "Genomics: drugs, diabetes and cancer" 470 : 338-339, 2011

44 Suzuki K, "Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3" 99 : 846-852, 2002

45 Li M, "Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels" 65 : 8200-8208, 2005

46 Yuan-Jing F, "Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis" 284 : 189-197, 2009

47 Raffoul JJ, "Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest" 6 : 107-, 2006

48 Davis JN, "Genistein inhibits NF-kappa B activation in prostate cancer cells" 35 : 167-174, 1999

49 Yoshimura R, "Expression of cyclooxygenase-2 in prostate carcinoma" 89 : 589-596, 2000

50 Messina MJ, "Emerging evidence on the role of soy in reducing prostate cancer risk" 61 : 117-131, 2003

51 Onozawa M, "Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP" 28 : 360-363, 1998

52 Dalais FS, "Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer" 64 : 510-515, 2004

53 Nagata Y, "Dietary isoflavones may protect against prostate cancer in Japanese men" 137 : 1974-1979, 2007

54 Lakshman M, "Dietary genistein inhibits metastasis of human prostate cancer in mice" 68 : 2024-2032, 2008

55 Garcea G, "Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration" 90 : 1011-1015, 2004

56 Bartkova J, "DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis" 434 : 864-870, 2005

57 Blasiak J, "DNA damage and repair in type 2 diabetes mellitus" 554 : 297-304, 2004

58 Fujita H, "Cyclooxygenase-2 promotes prostate cancer progression" 53 : 232-240, 2002

59 Mukhopadhyay A, "Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation" 21 : 8852-8861, 2002

60 Sandur SK, "Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism" 28 : 1765-1773, 2007

61 Li M, "Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway" 67 : 1988-1996, 2007

62 Shankar S, "Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis" 7 : 16-, 2008

63 Beevers CS, "Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells" 119 : 757-764, 2006

64 Deng G, "Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro" 14 : 116-121, 2008

65 Hour TC, "Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation" 51 : 211-218, 2002

66 Zhang HN, "Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP" 28 : 423-430, 2007

67 Mukhopadhyay A, "Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines" 20 : 7597-7609, 2001

68 Nakamura K, "Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines" 21 : 825-830, 2002

69 Tsui KH, "Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells" 29 : 661-668, 2008

70 Iqbal M, "Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention" 324 : 157-164, 2009

71 Bhandarkar SS, "Curcumin as an inhibitor of angiogenesis" 595 : 185-195, 2007

72 Balogun E, "Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element" 371 (371): 887-895, 2003

73 Zerbini LF, "Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer" 63 : 2206-2215, 2003

74 Akaza H, "Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents" 34 : 86-89, 2004

75 Ide H, "Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen" 70 : 1127-1133, 2010

76 Duvoix A, "Chemopreventive and therapeutic effects of curcumin" 223 : 181-190, 2005

77 Surh YJ, "Cancer chemoprevention with dietary phytochemicals" 3 : 768-780, 2003

78 Anand P, "Bioavailability of curcumin: problems and promises" 4 : 807-818, 2007

79 Khan N, "Apoptosis by dietary agents for prevention and treatment of prostate cancer" 17 : 39-52, 2010

80 Menon VP, "Antioxidant and anti-inflammatory properties of curcumin" 595 : 105-125, 2007

81 Thangapazham RL, "Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome" 7 : 1427-1435, 2008

82 Halazonetis TD, "An oncogene-induced DNA damage model for cancer development" 319 : 1352-1355, 2008

83 Steelman LS, "Akt as a therapeutic target in cancer" 12 : 1139-1165, 2008

84 Fujimoto K, "Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men" NATURE PUBLISHING GROUP 11 : 252-257, 200801

85 Gorgoulis VG, "Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions" 434 : 907-913, 2005

86 Cosentino C, "ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair" 30 : 546-555, 2011